Amphetamine, ecstasy and cocaine - Clinical aspacts of acute poisoning;Amphetamin, ecstasy og cocain - Kliniske aspekter hos den akut forgiftede patient

Ugeskrift for Laeger

Volumn 161, Issue 50, 1999, Pages 6907-6911

  Hedetoft, Christoffer ^a   Christensen, Hanne Rolighed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CENTRAL STIMULANT AGENT; COCAINE; PSYCHEDELIC AGENT; STREET DRUG;

COCAINE DEPENDENCE; DRUG ABUSE; EMERGENCY; HUMAN; INTOXICATION; REVIEW;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; EMERGENCIES; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OVERDOSE; POISONING; STREET DRUGS;

EID: 0033552519     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Politiets årsberetning. Informationstjenesten (afd. E) Rigspolitiet. København, Rigspoliticheten, 1997.
2. Årsberetning om Narkotikasituationen i Den Europæiske Union. Det Europæiske overvågningscenter for narkotika og narkotikamisbrug (EMCDDA). Luxembourg: Kontoret for de europæiske fællesskabers officielle publikationer, 1998.
3. Rumack BH, Toll LL, Gelman CR, eds. Poisindex(r) system vol 100. Englewood, Colorado: Micromedex Inc., 1999.
4. Olsen TG. Notat om ecstacy. København: Narkotikarådet 1996.
5. Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with »ecstasy« and »eve« misuse. J Clin Pathol 1996; 49: 149-53.
6. Coore JR. A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4-methylenedioxyamphetamine toxicity. J R Soc Med 1996; 89: 51-2.
7. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (»ecstasy«). Lancet 1992; 340: 384-7.
8. Mueller PD, Korey WS. Death by »Ecstasy«: The Serotonin Syndrome? Ann Emerg Med 1998; 32: 377-80.
9. Ramcharan S, Meenhorst PL, Otten JMMB, Kóks CHW, Boer D. Maes RAA et al. Survival after massive ecstasy overdose. ClinToxicol 1998; 36: 727-31.
10. Chan P, Chen JH, Lee MH, Deng JF. Fatal and nonfatal methamphetamine intoxication in the intensive care unit. Clin Toxicol 1994; 32: 147-55.
11. Benowitz NL. Clinical Pharmacology and Toxicology of cocaine. Pharmacol & Toxicol 1993; 72: 3-12.
12. Ellenhorn MJ. Medical toxicology. 2nd ed. Baltimore: Williams & Wilkins, 1997.
13. Murthy BVS, Roberts NB, Wilkes RG. Biochemical implications of ecstacy toxicity. Ann Clin Biochem 1997; 34: 442-5.
14. Schwab M, Seyringer E, Brauer RB, Hellinger A, Griese EU. Fatal MDMA intoxication [letter]. Lancet 1999; 353: 593-4.
15. Henry JA, Hill IR. Fatal interaction between ritonavir and MDMA [letter], Lancet 1998; 352: 1751-2.
16. Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med 1994; 24: 68-76.
17. Czerwinski WP. amphetamine-related disorders. J La State Med Soc 1998; 150: 491-9.
18. Evanko D. »Designer drugs«. Treating the damage caused by basement chemists. Postgrad Med 1991; 89: 67-71.
19. Steele TD, McCann UD, Ricaurte GA. 3,4-methylenedioxymethamphetamine (MDMA, »Ecstasy«): pharmacology and toxicology in animals and humans. Addiction 1994; 89: 539-51.
20. Karch SB, Stephens BG, Ho CH. Methamphetamine-Related Deaths in San Fransisco: Demographic, Pathologic, and Toxicologic Profiles. J Forensic Sci 1999; 41: 359-68.
21. Brody SL, Wrenn KD, Wilber MM, Slovis CM. Predicting the severity of cocaine-associated rhabdomyolysis. Ann Emerg Med 1990; 19: 1137-43.
22. Sternbach GL, Varon J. »Designer drugs«. Recognizing and managing their toxic effects. Postgrad Med 1992; 91:169-71, 175-6.
23. Derlet RW, Albertson TE. Emergency department presentation of cocaine intoxication. Ann Emerg Med 1989; 18: 182-6.
24. Sporer KA, Firestone J. Clinical course of crack cocaine body stuffers. Ann Emerg Med 1997; 29: 596-601.
25. Derlet RW, Heischober B. Methamphetamine. Stimulant of the 1990s? West J Med 1990; 153: 625-8.
26. Williams RG, Kavanagh KM, Teo KK. Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system. Can J Cardiol 1996; 12: 1295-301.
27. Katsumata S, Sato K, Kashiwade H, Yamanamis, Zhou I, Yonemura H et al. Sudden death due presumably to internal use of methamphetamine. Forensic Sci Inter 1993; 62: 209-15.
28. Malbrain ML, Neels H, Vissers K, Demedts P, Verbraeken H, Daelemans R et al. A massive, near-fatal cocaine intoxication in a body-stuffer. Case report and review of the literature. Acta Clin Belg 1994; 49: 12-8.
29. Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med 1988; 17: 282-3.
30. Loper KA. Clinical toxicology of cocaine. Med Toxicol Adverse Drug Exp 1989; 4: 174-85.
31. Kristensen MB, Friis H, Rassing MR. Lægemiddelkataloget 1999. København: Dansk Lægemiddelinformation A/S, 1999.
32. Furst SR, Fallon SP, Reznik GN, Shah PK. Myocardial infarctions after inhalation of methamphetamine. N Engl J Med 1990; 323: 1147.
33. Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3.4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core Body temperature ind the rat. J Neurosci 1998; 18: 5086-94.
34. Walubo A. Seger D. Fatal multi-organ failure after suicidal overdose with MDMA, »ecstasy«: case report and review of the literature. Hum Exp Toxicol 1999; 18: 119-25.
35. Silva MO, Roth D, Reddy KR, Fernandez JA, Albores-Saavedra J, Schiff FR. Hepatic dysfunction accompanying acute cocaine intoxication. J Hepatol 1991; 12: 312-5.
36. Leikin JB, Krantz AI, Zell-Kanter M, Barkin RL, Hryhorczuk DO. Clinical features and management of intoxication due to hallucinogenic drugs. Med Toxicol Adverse Drug Exp 1989; 4: 324-50.
37. Abraham HD, Aldridge AM. Adverse consequences of lysergic acid diethylamide. Addiction 1993; 88: 1327-34.
38. Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998; 31: 729-36.
39. Bernasconi R, Mathivel P, Bischoff S, Marescaux C. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol Sci 1999; 20: 135-41.
40. Gelman CR, Rumack BH, Hulchison TA. Drugdex(r) system vol. 100. Englewood, Colorado, Micromedex Inc 1999.